Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.98
Delayed Data
As of Jun 21
 -0.05 / -0.99%
Today’s Change
3.92
Today|||52-Week Range
8.38
+7.10%
Year-to-Date

Today’s Trading

Previous close5.03
Today’s open5.05
Day’s range4.93 - 5.09
Volume1,177,554
Average volume (3 months)1,126,772
Market cap$684.1M
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)+5.92%
Earnings growth (this year)+58.45%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+89.60%
P/E ratioNM
Price/Sales8.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENTAEnanta Pharmaceutica...+3.68+3.19%
TGTXTG Therapeutics Inc-0.75-5.14%
PTCTPTC Therapeutics Inc+0.67+1.88%
ADROAduro Biotech Inc-0.35-4.37%
Data as of 4:00pm ET, 06/21/2018

Financials

Next reporting dateJuly 31, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$60.6M
Annual profit (last year)-$163.4M
Net profit margin-269.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jodie P. Morrison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts